Advanced Wound Care Market 2018 Analysis Focusing On Zimmer Biomet, Smith & Nephew, Olympus, Mölnlycke, Misonix, Medtronic, Lohmann & Rauscher, Integra LifeSciences, Hollister Incorporated, Coloplast, BSN medical, B. Braun Group

The Global Advanced Wound Care Market is increasing the forecast years of 2018-2025 and pulling the Wound Care Devices industry with it. The Advanced Wound Care Market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. The Global Advanced Wound Care Market report is generated based on the market type, size of the organization, availability on-premises and the end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Furthermore, it attempts to determine the impact of Buyers, Substitutes, New entrants, Competitors, and Suppliers on the market.

The Global Advanced Wound Care Market is expected to reach USD 24,054.5 billion by 2025 and is projected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Free Sample Copy of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market

Rising aging population, growing incidences of diabetes, technological advancement, rising awareness regarding new technology, government support in the terms of funding, reduced the duration of hospital stays, rising incidence of chronic wounds, problem associated with ineffective traditional wound healing method, increase funding in wound care and development, increasing volume of surgeries across the globe, faster recovery and healing time, range of wound indications at relatively lower prices, innovative products and rising demand in emerging healthcare market are some of the drivers contributing to the growth of the market.

Global Advanced Wound Care Market, By Type (Dressing, Biologics, Therapy Devices), By Wound Type (Surgical Wound, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Others), By End-User (Hospitals, Wound Care Centers, Ambulatory Centers, Home Healthcare, Clinics, Community Healthcare), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa)- Industry Trends and Forecast to 2025

Some of the major market players in this market are -

PAUL HARTMANN Ltd,
Organogenesis Inc,
Advanced Medical Solutions Group plc,
Advancis Medical UK,
Arobella Medical,
B. Braun Melsungen AG,
BioMonde,
BSN medical,
Coloplast Group,
Hollister Incorporated,
Integra LifeSciences,
ITALIA MEDICA SRL,
LOHMANN & RAUSCHER GMBH,
Medtronic,
Misonix,
Mölnlycke Health Care AB,
Olympus Corporation,
Smith & Nephew,
Söring GmbH,
Zimmer Biomet

Order a Copy of Global Advanced Wound Care Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-advanced-wound-care-market

FACTORS DRIVING GROWTH IN THE GLOBAL ADVANCED WOUND CARE MARKET

Rising Incidences Of Chronic Wound:

Chronic wounds are rarely seen in individuals. In fact, chronic wound patients frequently suffer from “highly branded” diseases such as diabetes and obesity. Some of the most common types of wounds are Infectious wounds, Ischemic wounds, radiation poisoning wounds and surgical wounds. Ulcers is the most common type of chronic wounds, some of the most common types of ulcers are arterial ulcers, venous ulcers, diabetic ulcers and pressure ulcer. Tree of Chronic wound is growing steadily; it increases the incidence of chronic wound in individuals. People are suffering from different type of wounds and ulcers. This is sheen mostly in aging population.

In 2017, in the United States, chronic wounds affect around 6.5 million patients. It is claimed that more than USD 25 billion is spent annually on treatment of chronic wounds and patients affected by chronic wound are rapidly increasing. Whereas, in U.K. the cost to the National Health Service of caring for patients with chronic wounds were estimated at USD 3.4–4.6 billion per year.

Diabetic foot is a public health issue and is rare studies investigated its global epidemiology. In 2017, the global diabetic foot ulcer prevalence was 6.3%. It was higher in males and in fact higher in type 2 diabetic patients than in type 1 diabetics. North America had the highest prevalence 13.0%, and the prevalence in Asia, Europe, and Africa were 5.5%, 5.1% and 7.2%. According to the survey the patients with diabetic foot ulcer were older, longer diabetic duration and diabetic retinopathy, had a lower body mass index had more hypertension, and smoking history than patients without diabetic foot ulceration. According to the international journal of Endocrinology the incidence of diabetic ulcers is 5.62%. The risk of diabetic foot ulcer in patients with diabetes is 2.0%. The incidence of diabetic foot ulceration is expected to increase to 17 to 60% worldwide.

As the number of diabetic patients are increasing, this will lead to increase in the diabetic ulcers and chronic wounds, which in turn is expected to grow this, market in future.

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-advanced-wound-care-market

Segmentation: Global Advanced Wound Care Market

By Wound Type

• Surgical Wound
• Diabetic Ulcer
• Burns, Pressure Ulcer
• Venous Ulcer
• Others

By Distribution Channel

• Direct Tenders
• Retails

By End-Users

• Hospitals, Wound Care Centers
• Ambulatory Centers
• Home Healthcare
• Clinics
• Community Healthcare

By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com

Table of Contents:

1 INTRODUCTION

1.1 OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
1.2 CURRENCY AND PRICING
1.3 LIMITATION
1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING AGEING AND GERIATRIC POPULATION
3.1.2 TECHNOLOGICAL ADVANCEMENT
3.1.3 GOVERNMENT SUPPORT
3.1.4 RISING INCIDENCES OF CHRONIC WOUND
3.1.5 INCREASING TREND

3.2 RESTRAINTS

3.2.1 LOW AWARENESS
3.2.2 SLOW GROWTH RATE AND SHRINKING MARKET
3.2.3 COMPLEX REGULATORY APPROVAL PROCESS
3.2.4 COMPETITION WITH OTHER MOIST DRESSINGS

3.3 OPPORTUNITIES

3.3.1 REIMBURSEMENT
3.3.2 MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.3.3 UNMET NEEDS
3.3.4 INCREASING DEMAND

3.4 CHALLENGES

3.4.1 SHORTAGE OF TRAINED STAFF
3.4.2 THE DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.5 KEY MARKET TRENDS AND UPCOMMING TECHNOLOGIES
3.5.1 SMART DRESSING WILL PUSH FUTURE GROWTH
3.5.2 HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
3.5.3 ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
3.5.4 FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 DRESSING

6.2.1 DRESSING ON THE BASIS OF PRODUCT TYPE

6.2.1.1 FILM DRESSINGS
6.2.1.2 FOAM DRESSINGS
6.2.1.3 HYDROGELS
6.2.1.4 ALGINATES
6.2.1.5 WOUND CONTACT LAYER
6.2.1.6 SUPER ABSORBENT DRESSING

6.3 BIOLOGICS

6.3.1 BIOLOGICS ON THE BASIS OF PRODUCT TYPE

6.3.1.1 ALLOGRAFTS

6.3.1.2 SYNTHETIC SKIN GRAFTS

6.3.1.3 XENOGRAFTS

6.3.1.4 GROWTH FACTORS

6.3.1.4.1 PLATELET DERIVED GROWTH FACTOR (PDGF)
6.3.1.4.2 PLATELET RICH PLASMA (PRP)
6.3.1.4.3 EPIDERMAL GROWTH FACTORS (EGF)
6.3.1.4.4 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
6.3.1.4.5 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
6.3.1.4.6 TALACTOFERRIN ALFA
6.3.1.4.7 THROMBIN PEPTIDE
6.3.1.4.8 KERATINOCY GROWTH FACTOR (KGF)

6.4 THERAPY DEVICES

6.4.1 THERAPY DEVICES ON THE BASIS OF PRODUCT TYPE

6.4.1.1 NEGATIVE PRESSURE WOUND THERAPY (NPWT)

6.4.1.1.1 PORTABLE NPWT DEVICES
6.4.1.1.2 DISPOSABLE NPWT DEVICES

6.4.1.2 PRESSURE RELIEF DEVICES

6.4.1.3 HYPERBARIC OXYGEN CHAMBERS

6.4.1.3.1 MONOPLACE
6.4.1.3.2 MULTIPLACE
6.4.1.3.3 TOPICAL

6.4.1.4 WOUND DEBRIDEMENT DEVICES

6.4.1.4.1 HYDROSURGICAL
6.4.1.4.2 ULTRASOUND
6.4.1.4.3 MECHANICAL
6.4.1.4.4 OTHERS

6.4.1.5 PHYSICAL THERAPIES

6.4.1.5.1 LASER THERAPY
6.4.1.5.2 ELECTRICAL STIMULATION
6.4.1.5.3 EXTERNAL SHOCK WAVE THERAPIES
6.4.1.5.4 SALINE MIST THERAPY

7 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE

7.1 INTRODUCTION

7.2 SURGICAL WOUND

7.2.1 CLASS I
7.2.2 CLASS II
7.2.3 CLASS III
7.2.4 CLASS IV

7.3 DIABETIC ULCERS

7.4 PRESSURE ULCERS

7.5 VENOUS ULCERS

7.6 BURNS

8 GLOBAL ADVANCED WOUND CARE MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 WOUND CARE CENTERS
8.4 AMBULATORY CENTERS
8.5 HOME HEALTHCARE
8.6 CLINICS
8.7 COMMUNITY HEALTHCARE

9 GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW
9.2 DIRECT TENDERS
9.3 RETAIL

10 GLOBAL ADVANCED WOUND CARE MARKET BY GEOGRAPHY

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 NETHERLANDS
10.3.8 SWITZERLAND
10.3.9 BELGIUM
10.3.10 TURKEY
10.3.11 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN
10.4.2 CHINA
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 AUSTRALIA
10.4.6 THAILAND
10.4.7 SINGAPORE
10.4.8 MALAYSIA
10.4.9 PHILIPPINES ADVANCED WOUND CARE MARKET
10.4.10 INDONESIA
10.4.11 REST OF ASIA-PACIFIC

10.5 SOUTH AMERICA

10.5.1 BRAZIL
10.5.2 REST OF SOUTH AMERICA

10.6 MIDDLE EAST AND AFRICA

10.6.1 SOUTH AFRICA
10.6.2 SAUDI ARABIA
10.6.3 UNITED ARAB EMIRATES
10.6.4 REST OF MIDDLE EAST AND AFRICA

11 GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE

11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)

12 COMPANY PROFILE

12.1 ACELITY L.P. INC. (SUBSIDARY OF ALLARGAN)

12.1.1 COMPANY OVERVIEW
12.1.2 COMPANY SHARE ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 RECENT DEVELOPMENTS

12.2 SMITH AND NEPHEW

12.2.1 COMPANY OVERVIEW
12.2.2 COMPANY SHARE ANALYSIS
12.2.3 REVENUE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS

12.3 MOLNLYCKE HEALTHCARE

12.3.1 COMPANY OVERVIEW
12.3.2 COMPANY SHARE ANALYSIS
12.3.3 GLOBAL PRESENCE
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS

12.4 3M

12.4.1 COMPANY OVERVIEW
12.4.2 COMPANY SHARE ANALYSIS
12.4.3 REVENUE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS

12.5 BAXTER

12.5.1 COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENTS

12.6 COLOPLAST

12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS

12.7 CONVATEC INC.

12.7.1 COMPANY OVERVIEW
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENTS

12.8 DERMA SCIENCES INC (SUBSIDIARY OF INTEGRA LIFE SCIENCES)

12.8.1 COMPANY OVERVIEW
12.8.2 GLOBAL PRESENCE
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENTS

12.9 ETHICON INC (SUBSIDIARY OF JOHNSON AND JOHNSON SERVICES, INC )

12.9.1 COMPANY OVERVIEW
12.9.2 GLOBAL PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS

12.10 INTEGRA LIFE SCIENCES CORPORATION

12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS

12.11 PAUL HARTMANN LIMITED

12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT

12.12 ORGANOGENESIS INC

12.12.1 COMPANY OVERVIEW
12.12.2 GLOBAL PRESENCE
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS

View Full Report @ https://databridgemarketresearch.com/reports/global-advanced-wound-care-market/

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.